Product Overview

Brivaracetam API is a third-generation AED, or antiepileptic medication.

It binds to the synaptic vesicle protein 2A (SV2A) in a selective and high-affinity way.

This process controls the release of neurotransmitters at synapses, which stabilizes neuronal excitability and lowers the number of seizures.

Brivaracetam API has 10–30x higher binding affinity for SV2A than Levetiracetam.

This means that it can control seizures well at lower doses and is easier to handle.

It is mostly used to treat partial-onset (focal) seizures in adults, teens, and kids.

It was created to stringent GMP standards.

You can use it in medicines like tablets, oral solutions, and shots.

Therapeutic Applications

Therapeutic Class: Antiepileptic / Anticonvulsant.

Specification Parameters

Packaging & Storage

For proper packaging and storage, we take all the required measures:

HDPE barrels or fiber containers that can hold from a small quantity to a large quantity.

We ensure to put two polyethylene bags into airtight containers to keep the material secure.

You can get custom packaging for R&D, pilot, and commercial scale if you ask.

Always a better choice to keep it in the fridge at 2°C to 8°C.

Put the container well closed and out of the sun, moisture, and heat.

Make sure that handling is done according to GMP and GDP rules.

Shelf life is from 24 to 36 months from the date of manufacture if stored correctly.

Why Choose Us